Aim Peripheral artery disease is common in people with diabetes-related foot ulceration and is a risk factor for amputation. The best method for the detection or exclusion of peripheral artery disease is unknown. This study investigated the utility of clinical examination and non-invasive bedside tests in screening for peripheral artery disease in diabetes-related foot ulceration.
Introduction
Diabetes mellitus affects large numbers of people globally. Worldwide there has been a dramatic increase in the prevalence, resulting in an inevitable rise in diabetes-related complications and costs [1, 2] . It is estimated that foot ulceration associated with diabetes and diabetes cost the National Health Service (NHS) £1 billion annually in England [3] . As diabetes becomes more prevalent, these costs are likely to increase. Diabetes mellitus is an important factor implicated in the development of both peripheral artery disease and foot ulceration. In the general population with diabetes, the prevalence of peripheral artery disease is 10-26%; in people with associated foot ulceration this increases to > 50% [4] [5] [6] . It is imperative to identify peripheral artery disease, which is associated with both delayed healing and amputation, so that appropriate interventions can be offered [7] .
National guidelines recommend that all individuals with diabetes-related foot ulceration are managed by a multidisciplinary foot care team. In England and Wales, 31.0% of sites do not have a multidisciplinary team and of those that do, only 61.5% include a vascular surgeon [8] . Focused clinical examination of the feet, particularly palpation of foot pulses, remains fundamental to assessment [9, 10] . Nevertheless, palpation of foot pulses, especially in the presence of peripheral neuropathy, can be unreliable in screening for the presence of peripheral artery disease in people with diabetes [11] . A range of non-invasive bedside screening tests are available as an adjunct to clinical examination, including ankle-brachial pressure index (ABPI), toe-brachial index (TBI) and transcutaneous pressure of oxygen (TcPO 2 ) [9] .
Non-invasive screening tests for the detection of peripheral artery disease among individuals with diabetes are considered important to estimate the risk of amputation, ulceration, wound healing and the presence of cardiovascular disease, yet there are no consensus recommendations to support one modality over another [12, 13] . Surprisingly, to date, the number of studies assessing the utility of peripheral artery disease screening tests in people with established ulceration has been limited in both number and scope [9] . Most studies have either excluded or not separately reported the efficacy of peripheral artery disease screening tools in people with ulceration. Those studies that did detail assessment of people with ulceration have investigated only a narrow range of tools. This is unfortunate as the identification of peripheral artery disease is more influential on diabetes management in the cohort with ulceration than those with intact feet. This is the first study to investigate the efficacy of both clinical assessment and a wide battery of peripheral artery disease screening tools in individuals with diabetes-related foot ulceration.
Participants and methods
Ethical approval for the study was granted by the NHS Health Research Authority (NRES) Committee LondonCity Road and Hampstead (Reference 12/LO/1579) and the research was performed according to the Declaration of Helsinki (2008).
Study design and participants
People with diabetes presenting to either a multidisciplinary diabetes foot clinic or emergency department with foot ulceration of < 2 months duration were recruited into this prospective, single-centre observational study at a large teaching hospital.
All individuals with diabetes, regardless of type, presenting with primary lower limb ulceration were potentially eligible. Exclusion criteria were: aged < 18 years, previous revascularization, non-diabetes related ulceration, lacking capacity to consent to inclusion in the study and pregnant. Informed, written consent was obtained from all those willing to participate in the study.
All study assessments were undertaken during routine clinical visits. Patient management followed routine local protocols which are themselves compliant with national guidance [14] .
Clinical and radiological assessors
Participants were assessed clinically, and the screening were tests performed by a single post-completion of training vascular surgical fellow, experienced in the management of diabetes-related ulceration and familiar with the screening tools. Additional training was provided to the screener by the vascular laboratory for toe pressure and TcPO 2 assessment to ensure compliance with the manufacturer's recommendation.
Patients and their medical records were consulted for demographic data.
Clinical examination included documentation of characteristics of the lower limbs, namely hair loss, muscle atrophy, dependent rubor, cool skin, blue or purple skin, capillary refill time and venous filling time. A capillary refill time of > 2 s and a venous filling time of > 15 s were classified as screen positive for peripheral artery disease. Other clinical examination criteria were recorded as present or absent based on the assessor's subjective judgement.
The presence of peripheral neuropathy was determined using a 10-G monofilament applied to the tips of the first, third and fifth toes, and the dorsum of both halluces for 2 s [15] . Absence of sensation in any one of these areas was classified as neuropathy. Peripheral pulses (femoral, popliteal, dorsalis pedis and posterior tibial) were palpated bilaterally. Absent pedal pulses were classified as indicating peripheral arterial disease.
The ulcer was examined, and the severity was staged using the Site, Ischemia, Neuropathy, Bacterial infection, Area, Depth (SINBAD) classification [15, 16] . The Society of Vascular Surgery Wound Infection Ischaemia (SVS WIfI) score was used to classify the clinical status of the foot [17] .
Screening tests
Screening tests were performed after a 20-min rest period at room temperature (18-20°C) room. Participants were placed in a 30°reclined position on a clinical examination couch. A duplex ultrasound scan was performed by a single experienced What's new?
• We evaluated the utility of clinical examination and non-invasive bedside tests in screening for peripheral artery disease in people with diabetes. This study is unique in both the wide variety of tests investigated and that all participants had ulceration.
• Screening tests must reliably exclude the disease, as it is associated with both failure to heal and major amputation. We demonstrate that only toe-brachial index and tibial waveform analysis would be considered suitable for screening to exclude peripheral artery disease. Simple bedside clinical examinations such as pulse assessment are unreliable in excluding peripheral artery disease in this cohort.
and accredited vascular sonographer. The investigator and sonographer were blinded to each other's findings.
Ankle pressure and ankle-brachial pressure index
Ankle and brachial pressures were measured using a manual inflatable cuff and a handheld continuous-wave Doppler probe (Huntleigh Dopplex MD2, Huntleigh, UK). Ankle pressure of < 70 mmHg was considered abnormal. A resting ABPI was performed using the brachial pressure on the right arm and the pressure values at the level of the posterior tibial artery and dorsalis pedis artery. The highest calculated ABPI value was used in the analysis with a value < 0.9 or > 1.3 classified as abnormal.
Toe pressures, toe-brachial pressure index and TcPO 2
Toe pressures were measured using a laser Doppler probe and toe pressure cuff (Periflux 5000 with PF 5010 laser Doppler perfusion monitor unit and PF 5050 pressure unit with PF 5051 pressure accessory kit, Perimed AB, Datav€ agen, Sweden) on the largest available toe. Three separate readings were obtained over a 5-min interval and the mean of the values was used. Toe pressure of < 50 mmHg was considered abnormal. A TBI of ≤ 0.75 was considered abnormal. TcPO 2 measurements were taken from the dorsum of the foot using (Periflux 5000 with PF 5010 laser Doppler perfusion monitor unit and PF 5020 temperature unit, Perimed AB). The skin was cleaned with normal saline, an adhesive ring applied and the manufacturer's recommended contact liquid introduced. The probe was then attached and left in place for 15 min while the trace was recorded. TcPO 2 < 60 mmHg was considered abnormal [18] .
Pole test
The pole test was performed using a handheld Doppler probe (Huntleigh Dopplex MD2). With the patient supine, the leg was elevated passively at the hip while continuing to listen for the Doppler signal. The height (in cm) at which the Doppler signal was lost was recorded. To confirm that flow was lost, the leg was lowered and considered positive if the flow to the vessel returned. The test was repeated on both the dorsalis pedis and posterior tibial arteries bilaterally. The highest of the two measurements was used for analysis. If there was no loss of flow or the patient was unable to elevate the leg, this was recorded [19, 20] .
Waveform analysis
Waveforms recorded at the level of the distal tibial arteries were included in the analysis to verify whether Doppler waveforms at this level could be discriminatory in identifying peripheral artery disease. Recordings were made at the level of the medial malleolus, the dorsalis pedis and in the mid-calf for the peroneal artery. It is important to note that this part of the analysis was not blinded, i.e. the vascular sonographer performing the reference scan also performed the tibial waveform analysis.
Gold standard test
A duplex ultrasound scan was performed by an accredited vascular scientist using a GE Logic E9 ultrasound scanner (GE, Green Bay, WI, USA). The abdominal, femoral and lower limb arteries (femoral, popliteal and tibial) supplying the ulcerated limb were studied. A C5-1 MHz curvilinear array was used to assess the abdominal vessels, whereas a linear 3-9 MHz transducer was used for the lower limb arteries. All arteries were examined by using a combination of B-mode imaging, colour Doppler and spectral Doppler ultrasound in transverse and longitudinal planes. Peak systolic velocity (PSV) was measured throughout the iliac, femoral, popliteal and tibial arteries and recorded for further analysis only in the distal tibial arteries. PSV was measured at the point in the vessel where the highest velocity was detected. The PSV ratio between a stenosed region and the proximal PSV was used to grade stenosis and was classified as abnormal when the PSV ratio was > 2, which represents a stenosis of > 50%.
Flow velocity waveforms were also recorded. Triphasic or biphasic waveforms with a fast systolic rise time and no flow at end-diastole were considered normal lower limb resting waveforms. Monophasic (damped) waveforms were considered abnormal and indicative of proximal arterial obstructive disease. At the site of a stenosis the flow waveform has abnormally high velocities throughout the cardiac cycle with a ragged outline due to the presence of turbulent flow. Distal to a stenosis the waveform is damped with a prolonged systolic rise time and forward flow throughout the cardiac cycle.
Peripheral artery disease was defined as > 50% stenosis in any named lower limb artery or monophasic flow beneath a calcified segment [14, 21, 22] .
Statistical analysis
Statistical analysis was performed using R 3.1.1 (R Core Team, R Foundation for Statistical Computing, Vienna, Austria).
The negative likelihood ratio (NLR) was the primary outcome of interest. The positive likelihood ratio (PLR), sensitivity, specificity, positive and negative predictive values are also reported. The NLR is the probability of a negative test in an individual with the disease divided by the probability of a negative testing in an individual without the disease (1 À sensitivity/specificity). The PLR is the probability of a positive test in an individual with the disease divided by the probability of positive test in an individual without the disease (sensitivity/1 À specificity).
The likelihood ratios detail the extent to which the outcome of a test alters the pretest probability of disease. Interpretation is influenced by context but, in general, a NLR < 0.1 suggests that a test can reliably exclude disease and PLR > 10 can reliably confirm the presence of a disease [23] .
Results
Some 60 participants with diabetes-related foot ulceration were included in the study ( Table 1 ). The ulcer characteristics of the study participants are detailed in Tables 2 and 3 . A total of 20 (33%) participants had peripheral artery disease on diagnostic ultrasound.
The NLR and PLR of pedal pulse assessment (0.75, 1.38) and the other physical examination findings were poor (Table 4) . Similarly, the NLR and PLR of ABPI (0.53, 1.69), TcPO 2 (1.1, 0.81) and ankle pressure (0.67, 2.25) as screening tools to identify peripheral artery disease were unsatisfactory. The lowest NLR was for tibial waveform assessment (0.15) and TBI (0.24). The highest PLR were for toe pressure (17.55) and pole test at the ankle (10.29), but the NLR values were again poor at 0.56 and 0.74, respectively (Table 4) .
Discussion
The identification of peripheral artery disease is crucial to the management of diabetes-related foot ulceration because it risk stratifies people that are at greater risk of failure to heal, amputation and, perhaps more importantly, those who may potentially benefit from revascularization [7] . The most important characteristic of a screening tool in people with established ulceration is therefore the ability to exclude peripheral artery disease. Any screen-positive patient will need to undergo one or more reference investigations to Values are given as number of participants (%), except *median (range). † Hyperlipidaemia is defined as a previous documentation of (general practitioner or secondary care) or current cholesterol of > 5.2 mmol/l. The gold standard definition of peripheral arterial disease (PAD) used included monophasic (damped) waveforms in any vessel, therefore the specificity and positive predictive value ratios are 1 and, positive likelihood is effectively infinite and diagnoses PAD.
ª 2018 Diabetes UK confirm or exclude peripheral artery disease and detail the anatomy of the lower limb arterial tree. The consequences of a false negative are potentially more severe than the consequences of a false positive, as the initial diagnostic tests utilized by most units are non-invasive and unlikely to lead to harm. To this end a NLR < 0.1 provides convincing screening evidence that the disease is absent [23] . In our study, no test achieved this cut-off but the toe brachial pressure index and tibial waveform analysis, which almost reached this threshold, could be considered as screening tools, with caveats. In our study population, where prevalence was lower than the reported literature, TBI would have led to false negatives in two (10.5%) and tibial waveform analysis in three (7.0%) of those with peripheral artery disease. We therefore recommend that patients classified as screen-negative with these tests are monitored closely. A degree of clinician judgement is required but in practice those with severe ulceration, ulcer deterioration or failure to progress, should still undergo formal diagnostic imaging. We certainly recommend that clinicians without access to these tools request formal imaging to exclude peripheral artery disease. Unfortunately, the commonly used clinical assessments including pulse assessment and screening tests such as ankle pressure and ABPI are not very useful for disease exclusion in people with established ulceration. This analysis is consistent with previous research that has demonstrated that the utility of pulse assessment, ankle pressure and ABPI to identify peripheral artery disease in those with neuropathy (85% of our cohort) is low. It is anticipated that the utility of these tests diminishes further in individuals with ulceration. This is expected because oedema, calcification and arteriovenous shunting all increase with progression of diabetes and unduly influence the outcome of these screening tests [24] . Previous studies assessing the utility of ABPI in intact feet have demonstrated NLR values of < 0.1 to 0.5 [25, 26] . Although Aboyans et al. [26] reported a NLR of < 0.1 in a cohort with 94% ulceration, most other studies that explicitly include some individuals with ulcers report NLR values ranging from 0.3 to 0.7 [21, [26] [27] [28] . Williams et al. [29] reported that the NLR for TBI was < 0.1 for people with intact feet and neuropathy. Predictably, in our cohort with ulceration, TBI performed less well with a NLR of 0.24. Nevertheless, TBI probably represents the most useful screening tool for peripheral artery disease in the community foot clinic where access to diagnostic tests may be limited. Unfortunately, due to previous minor amputations or digital ulcers not all can undergo this investigation.
Waveform analysis was the best screening tool to exclude peripheral artery disease in our study and Normahani and colleagues [30] demonstrate that it is possible to train podiatrists to perform a focused duplex ultrasound scan of the tibial vessels at the ankle. The costs of training and the availability of ultrasound machines may be limitations. Medical devices are available that can record the ankle pulse waveform but their utility in individuals with established ulceration remains to be assessed [31] . We did not have access to this technology at the time of the study. An alternative is to refer all those with ulceration for a limited tibial waveform scan by a vascular sonographer. Only those who screen positive should then proceed to full duplex ultrasound.
Strengths and limitations
This study focused on the identification of peripheral artery disease as the primary outcome of interest. Despite its importance, not all those with peripheral artery disease require revascularization to heal their ulcer. An additional consideration is whether perfusion is adequate to heal the ulcer with best medical and wound care, i.e. is revascularization required? This is a more complex and different question and would require a different study design to reach a conclusion. Screening tools that exclude peripheral artery disease can help to identify individuals that are unlikely to benefit from more time-consuming and costly diagnostic investigations that sometimes expose the patient to nephrotoxic agents or radiation.
We chose a definition of abnormal ABPI of < 0.9 or > 1.3. Most studies assessing the utility of ABPI as a screening test for peripheral artery disease use a value of < 0.9. Our definition of abnormal ABPI was chosen because we restricted our study to those with established ulceration where robust exclusion is more important than specificity.
To our knowledge this is the first study to test such a wide variety of peripheral artery disease screening tools in individuals with ulceration. Other screening tools are available that were not included in this study such as pulse oximetry.
The clinical assessment of our participants was performed by a post-completion of training vascular fellow. The applicability of this assessment to non-specialist nurse or podiatrists is unknown. We anticipate that the ability of pulse assessment to exclude peripheral artery disease would be even worse if undertaken by non-specialists.
The size of the study was limited to 60 participants due to the time-consuming nature of performing such a wide battery of tests for each participant. Future studies or registries, validating the findings of this study, should focus on TBI and tibial waveform analysis alone to facilitate the inclusion of a larger number of patients. A larger study could also help to address the question of whether a combination of ulcer characteristics and these two tests could be used to more reliably exclude peripheral artery disease in people with diabetes-related foot ulceration.
Conclusions
TBI and tibial waveform analysis at the ankle are viable screening tools to exclude peripheral artery disease in people with foot ulceration where the equipment and training for their utilization exists or can be set up. However, even these tools can miss patients with peripheral artery disease so patients with severe ulceration, failure to progress or deterioration should undergo diagnostic vascular imaging. Traditionally used clinical assessment and alternative screening tools perform poorly in excluding peripheral artery disease in people with established diabetes-related foot ulceration. In the absence of appropriate TBI or tibial waveform analysis all individuals with diabetes-related foot ulceration should undergo diagnostic vascular imaging unless there is a very rapid response to best medical and wound care.
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